Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A
Yuni Yamaki(Kagoshima University), Hidetoshi Takada, Mahito Nakanishi(Tokiwa University), Koji Hisatake(University of Tsukuba), Masayuki Aso, Junko Kijima-Tanaka(University of Tsukuba), Ken Nishimura(University of Tsukuba), Aya Fukuda(University of Tsukuba), Naomi Yoshida(Tokiwa University), Takashi Fukushima(University of Tsukuba), Ryo Sumazaki(University of Tsukuba), Yoshihiro Miwa(University of Tsukuba), Tomoki Sakasai(University of Tsukuba)
Cited by 13
Related Papers
Characterization of oligonucleotide transport into living cells.
|Proceedings of the National Academy of Sciences|1989|740
Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
|Cell stem cell|2013|412
Development of Defective and Persistent Sendai Virus Vector
|Journal of Biological Chemistry|2010|373
Transient activation of <i>c-MYC</i> expression is critical for efficient platelet generation from human induced pluripotent stem cells
|The Journal of Experimental Medicine|2010|347
Protein Transduction Domain of HIV-1 Tat Protein Promotes Efficient Delivery of DNA into Mammalian Cells
|Journal of Biological Chemistry|2001|287